Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-rare-occurrence-serious-liver-injury-use-hepatitis-c-medicines-mavyret-zepatier-and

FDA
29 Aug 2019

https://endpts.com/fda-fires-off-a-warning-on-rare-cases-involving-death-adverse-liver-events-linked-to-misuse-of-3-big-hep-c-drugs/

John Carroll ENDPTS
29 Aug 2019

https://www.biopharmadive.com/news/fda-safety-warning-hepatitis-c-drugs-patient-deaths/561891/

Jacob Bell BIOPHARMADIVE
28 Aug 2019
The Biopharmaceutical Cartel And High Drug Prices
The Biopharmaceutical Cartel And High Drug Prices

10 Apr 2019

// John LaMattina FORBES

https://www.forbes.com/sites/johnlamattina/2019/04/10/the-biopharmaceutical-cartel-and-high-drug-prices/#4fb4c4e6533c

John LaMattina FORBES
10 Apr 2019

https://www.reuters.com/article/us-column-miller-medicare/medicare-part-d-no-match-for-runaway-specialty-drug-costs-study-idUSKCN1PW16X

Mark Miller REUTERS
07 Feb 2019

https://www.fiercepharma.com/manufacturing/merck-runs-out-parkinson-s-disease-drug-sinemet-as-manufacturing-issues-unexpected

Eric Palmer FIERCE PHARMA
04 Oct 2018